The India cystoscopy and ureteroscopy market size is projected to reach US$ 313.63 million by 2031 from US$ 180.00 million in 2023. The market is expected to register a CAGR of 7.2% during 2023–2031. The increasing inclination towards robotic-assisted urological procedures is likely to bring new trends in the market in the coming years.
Cystoscopy and ureteroscopy are medical procedures used to examine and treat conditions of the urinary tract, focusing on different areas of the urinary system. Cystoscopes and ureteroscopes consist of thin, flexible or rigid tubes with light and a camera attached to them, which help in the visualization of the interior of bladder and urethra for the treatment and diagnosis of urinary disorders. The market is mainly driven by the increasing prevalence of urological diseases and the development of technologically advanced and minimally invasive products. Additionally, the growing medical tourism industry in India is expected to create ample opportunities in the coming years.
The Indian government's initiatives such as Ayushman Bharat and the National Health Mission (NHM) are contributing significantly to the growth of the cystoscopy and ureteroscopy market. These programs focus on improving healthcare access, especially in rural areas, through the development of new healthcare centers, upgrades in existing facilities, and expansion of insurance coverages. These efforts have led to an increase in the awareness of specialized urological procedures such as cystoscopy (used for diagnosing bladder and urinary tract conditions) and ureteroscopy (used to treat kidney stones and other urological issues), particularly in rural areas where previously access to such services was limited.
The growth of medical tourism in India is further propelling the cystoscopy and ureteroscopy market. India is now a preferred destination for affordable, high-quality urological care, attracting international patients due to its advanced medical technologies and cost-effective treatment options. Hospital chains such as Apollo, Fortis, and Max Healthcare are capitalizing on this trend, with an upsurge in international patient footfall. These hospitals are also focusing on expanding their global outreach by establishing international offices that provide assistance with visa processes and travel arrangements, and make comprehensive treatment plans. According to the India Brand Equity Foundation 2024 report, Max Healthcare reported a remarkable 27% year-on-year growth in international patient revenue. Apollo Hospitals, a renowned choice for international patients, is targeting double-digit growth and plans to expand its global reach in the coming years.
Kidney stones, bladder cancer, prostate enlargement, urinary tract infections (UTIs), and other medical conditions related to the bladder and kidneys are common in India. The rising incidence can be associated with population aging, lifestyle factors, and genetic predispositions. As per the 2023 study "Risk Factors of Incident Kidney Stones in Indian Adults: A Hospital-Based Cross-Sectional Study," the prevalence of kidney stones in India is approximately 12%, and it is relatively higher in the northern part of India, i.e., 15%. In addition, India has a large number of patients with prostate-related issues and bladder cancer. As per the GLOBOCAN report, there were 37,948; 22,548; and 17,480 prostate, bladder, and kidney cancer cases, respectively, in India in 2022. These conditions often require diagnostic and therapeutic interventions such as cystoscopy and ureteroscopy. Cystoscopy allows examination of the urinary bladder, whereas ureteroscopy allows diagnosis and treatment of ureter and kidney conditions. Thus, these techniques are employed in stone removal and tumor diagnosis procedures, among others. These tools are widely adopted owing to their ease and effectiveness in diagnosing and treating urological conditions. Thus, the increasing prevalence of urological disorders is a significant factor driving the India growth.
India has emerged as one of the most popular medical tourism destinations in the world, particularly for the diagnoses and treatments of urological conditions. The country's healthcare system is renowned for its high-quality services at a fraction of the costs incurred in Western countries. International patients, particularly from regions such as the Middle East, Africa, and Southeast Asia, are increasingly choosing India for their medical treatments due to the affordability, quality of care, and availability of advanced medical technology. As per the India Tourism Statistics 2023, in 2022, there were 6.43 million Foreign Tourist Arrivals (FTAs) in India; 7.4% of these FTAs traveled for medical purposes. The Government of India recognizes the potential of medical tourism, and it has introduced various initiatives to promote its growth. These initiatives include the issuance of medical visas for foreign patients, partnerships with international hospitals, and the establishment of dedicated medical tourism facilitation centers. In 2024, the government launched an initiative called Heal in India as an effort to further boost its medical tourism. The Ministry of Health and Family Welfare, the Government of India, and the Ministry of Ayush have been collaborating with the Centre for Development of Advanced Computing and the Services Export Promotion Council to propel this initiative through the "One Step Heal" portal. Additionally, many top-tier Indian hospitals and healthcare institutions are accredited by international organizations such as the Joint Commission International (JCI), further enhancing the country's reputation as a healthcare hub.
Cystoscopy and ureteroscopy are among the most sought-after procedures by medical tourists seeking treatment for urological conditions such as kidney stones, bladder cancer, and prostate problems. The availability of state-of-the-art equipment and skilled urologists also makes the country an attractive destination for these procedures. Thus, as medical tourism continues to grow, the demand for cystoscopy and ureteroscopy is expected to rise, providing significant opportunities for healthcare providers and medical equipment manufacturers to expand their reach. Additionally, the flourishing medical tourism encourages hospitals and clinics to upgrade their infrastructure and equipment to cater to international patients. Thus, India's focus on strengthening its position as a global leader in medical tourism generates significant growth opportunities for the India market in the near future.
Key segments that contributed to the derivation of the India cystoscopy and ureteroscopy market analysis are product type, procedure, technology, usage type, and end user.
The India cystoscopy and ureteroscopy market is experiencing significant growth, driven by the increasing prevalence of urological conditions such as kidney stones, bladder cancer, and urinary tract infections (UTIs). Cystoscopy and ureteroscopy procedures are becoming essential diagnostic and therapeutic tools in the healthcare sector owing to their ability to provide visual access to the bladder, urethra, ureters, and kidneys. An upsurge in the cases of these conditions, combined with benefits conferred by minimally invasive procedures, propels the adoption of cystoscopes and ureteroscopes across hospitals in India. Leading healthcare providers such as Fortis Healthcare, Max Healthcare, and Medanta – The Medicity are integrating state-of-the-art flexible ureteroscopes and advanced cystoscopy techniques into their urological departments. These technologies offer superior precision, reduced recovery times, and better patient outcomes compared to traditional methods. For example, Fortis and Max Healthcare have implemented these advanced tools for treating kidney stones, one of the most common urological conditions in India. Medanta in Gurugram uses cutting-edge cystoscopy and ureteroscopy for the diagnosis and treatment of a range of urological disorders, which further enhances its reputation for high-quality care.
The regional trends and factors influencing the India Cystoscopy and Ureteroscopy Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses India Cystoscopy and Ureteroscopy Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 180.00 Million |
| Market Size by 2031 | US$ 313.63 Million |
| Global CAGR (2023 - 2031) | 7.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | India
|
| Market leaders and key company profiles |
The India Cystoscopy and Ureteroscopy Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the India Cystoscopy and Ureteroscopy Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The "India Cystoscopy and Ureteroscopy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
Cystoscopy and ureteroscopy are medical procedures used to examine and treat conditions of the urinary tract focusing on different areas of the urinary system. Cystoscope and ureteroscope are thin flexible and rigid tube with light and camera attached to it which helps in visualization of the interior of bladder and urethra for treatment and diagnosis of urinary disorders.
The market is estimated to grow with a CAGR of 7.2% from 2022 to 2028.
The market segmentation by product type is led by cystoscope segment that is growing significantly due to increasing innovation in cystoscopes along with wide applications and new product launches.
Key factors that are driving growth of the market are increasing prevalence of urological diseases and development of technologically advanced and minimally invasive products fuel the growth of the market.